secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inmune Bio, Inc. (INMB)
CIK:        0001711754
Form:       8-K
Filed at:   2023-12-18T23:59:59+00:00
Accession:  0001213900-23-096477
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 1.01, 3.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INmune Bio extends shareholder rights plan expiration to December 30, 2024
--------------------------------------------------------------------------

- Entered Amendment No. 3 to Rights Agreement, extending expiration from Dec 30, 2023 to Dec 30, 2024.
- Amendment No. 3 also updated notice provisions in the Rights Agreement.
- The rights plan was originally adopted in December 2020 and previously extended twice.
- No other substantive changes to the rights or terms of the agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1711754/000121390023096477/0001213900-23-096477-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1711754/000121390023096477/ea189976-8k_inmunebio.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-096477

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer